Bull Finder: IBRX, ANY, GTE, GMGMF Plus More Surging Stocks

New Post Public Reply Private Reply Replies (0) Message Board
louied91
56
Bull Finder: IBRX, ANY, GTE, GMGMF Plus More Surging Stocks Inside

https://thestreetreports.com/bull-finder-ibrx...ks-inside/  

Investor interest remains elevated across the small-cap and mid-cap markets as several companies announced significant corporate developments ranging from record revenue growth and strategic acquisitions to major institutional investments and transformational asset sales. The following companies are attracting increased attention from traders and investors.
ImmunityBio Inc. (NASDAQ: IBRX) Delivers Record Revenue Growth, Advances Regulatory Pipeline

ImmunityBio Inc. (NASDAQ: IBRX) reported another record quarter, highlighting accelerating commercial adoption of its flagship immunotherapy ANKTIVA® and continued progress across its oncology pipeline.

The Company reported record second-quarter 2026 net product revenue of $50.7 million, representing 92% year-over-year growth and marking its eighth consecutive quarter of sequential revenue growthsince the commercial launch of ANKTIVA. First-half 2026 net product revenue reached $94.8 million, an impressive 121% increase over the same period in 2025.

Beyond commercial execution, ImmunityBio continues to strengthen its long-term growth outlook. During July, the United Arab Emirates granted broad marketing authorization for ANKTIVAacross BCG-unresponsive non-muscle invasive bladder cancer indications. The U.S. FDA also accepted the Company’s supplemental Biologics License Application for review, assigning a January 6, 2027 PDUFA target date for ANKTIVA plus BCG in patients with papillary disease without CIS.

The Company also secured exclusive U.S. rights to develop and commercialize the Tokyo-172 BCG strain through an agreement with Japan BCG Laboratory, helping secure long-term treatment supply while advancing multiple late-stage clinical programs. ImmunityBio finished the quarter with more than $350 million in cash, cash equivalents and marketable securities, providing substantial financial flexibility to support future commercialization and clinical expansion.
Sphere 3D Corp. (NASDAQ: ANY) Draws Institutional Attention Following 6.5% Strategic Investment

Sphere 3D Corp. (NASDAQ: ANY), which is repositioning itself as an AI infrastructure and digital asset computing company, moved into focus after Endeavor Blockchain LLC disclosed a 6.5% ownership stake acquired through open market purchases completed between July 22 and July 30, 2026.

Joshua Kilgore, Managing Member of Endeavor Blockchain, stated the investment reflects his belief that Sphere 3D remains materially undervalued and offers meaningful opportunities for shareholder value creation. The filing further noted his intention to engage with management and the Board regarding strategic initiatives while retaining flexibility to increase or reduce the investment as market conditions evolve.

See News Article Now

The investment is particularly notable given Endeavor Blockchain’s focus on digital infrastructure, AI computing, high-performance computing (HPC), and digital asset mining, sectors that continue attracting significant institutional capital as demand for AI infrastructure accelerates.
Gran Tierra Energy Inc. (NYSE: GTE) Announces $1.33 Billion Transformational Sale

Gran Tierra Energy Inc. (NYSE: GTE) announced a transformative agreement to sell its Colombia and Ecuador operations to Maurel & Prom in a transaction valued at approximately $1.33 billion.

The transaction represents the sale of substantially all of the Company’s South American producing assets while positioning the remaining company for a dramatically stronger balance sheet. Upon closing, Gran Tierra expects to emerge debt-free with significant cash resources, while management estimates a pro forma proved developed producing (PDP) net asset value of approximately $12.49 per fully diluted share, representing an estimated 83% premium to the Company’s recent 20-day volume weighted average share price.

Management believes the transaction provides a fully financed platform for future growth while unlocking shareholder value through a significantly improved capital structure.
Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) Expands Global Visibility

Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) continues executing on its commercialization strategy after launching a completely redesigned corporate website and investor center that reflects the Company’s expanding global graphene initiatives.

The launch follows several major developments announced during recent months, including continued commercialization efforts for G® Lubricant, progress toward scaling production of its graphene aluminum-ion battery technology, expansion of its THS™ energy-saving coating products, and strategic collaborations designed to accelerate adoption of proprietary graphene manufacturing technologies.

Management has continued strengthening investor communications while advancing its mission of improving energy efficiency, reducing emissions, and commercializing practical graphene-based products across multiple industries. see www.graphenemg.com.
Market Movers Also Drawing Attention

Alongside today’s featured companies, traders are closely monitoring several momentum names making significant moves during early trading, including:

INLIF Ltd. (NASDAQ: INLF)
Jin Medical International Ltd. (NASDAQ: ZJYL)
Julong Holding Ltd. (NASDAQ: JLHL)

Each has experienced substantial early-session trading activity, increasing visibility among momentum traders and active investors searching for high-volume opportunities.

As market volatility continues creating new opportunities across healthcare, artificial intelligence infrastructure, advanced materials, energy, and emerging technology sectors, investors will be closely monitoring these companies for additional catalysts in the sessions ahead.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 35

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 24

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 29

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 15

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 42

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 33

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 27

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Gigli's Rise: Transforming THC Beverages into Mainstream Delights

Updated Category News Views 209

Gigli's Journey to Mainstream Success Gigli, an innovative THC beverage brand, is enjoying a significant rise in popularity as it makes its way into mainstream retail. The excitement around Gigli has fueled the sale of over 6 million cans since its introduction, signaling a change in how adults choose to celebrate life’s moments. With its recent placements in select...

Continue Reading
IBM's Q3 Earnings Show Growth Amidst AI Surges and Challenges

Updated Category News Views 195

IBM's Financial Performance in Q3 International Business Machines Corp (NYSE: IBM) recently released its financial results for the third quarter, reflecting a robust performance that highlighted the company’s continued adaptation to market demands. With a revenue of $16.33 billion, IBM surpassed analysts' expectations, indicating a healthy growth trend in its core...

Continue Reading
Explore Unmatched Black Friday Offers on Suunto Gear

Updated Category News Views 156

Experience Suunto's Unforgettable Black Friday Deals As Black Friday approaches, adventure enthusiasts have a golden opportunity to snag incredible deals from Suunto, a frontrunner in sports wearables. The renowned brand is excited to announce a range of exclusive offers that run from Thursday until the end of the sales period. Customers can indulge in savings up to 40%...

Continue Reading
The Promising Future of Feed Additives Market Growth

Updated Category News Views 137

Understanding the Feed Additives Market Growth As the global demand for efficient animal nutrition continues to soar, the Feed Additives market is set for remarkable expansion. Current estimations suggest that the market, valued at approximately USD 42.2 billion, will achieve an impressive growth, reaching USD 70.09 billion by 2032. This significant increase is expected...

Continue Reading
Kevin O'Leary Discusses Presidential Control Over Tariffs

Updated Category News Views 80

Kevin O'Leary Stands Firm on Trade Policy Authority Investor Kevin O'Leary recently expressed his views regarding the potential influence of the Supreme Court on President Trump's authority to set tariffs. He emphasized that retaining this power is essential for the presidency, particularly in navigating the complex landscape of international trade. Senior Executive...

Continue Reading